Soft tissue sarcomas are rare and heterogenous group of malignancies, arising from mesenchymal tissue. Collectively, sarcomas accout for 1% of all adult malignant tumours [1], and their incidence in our country is about 2.4 %oo [2], but despite of its rarity, it’s considered one of the most aggressive neoplasms with a high metastatic potential. The article focuses on the treatment outcomes in dependence of the applied therapy. In more detail, this study is based on the evaluation of recurrence rates of the disease, in patients treated by surgery alone, by combined treatment and the complex one.